HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹5.64 | ₹6.36 | ₹13.02 | ₹10.80 | ₹6.85 |
What is the latest Earnings Per Share (EPS) of HIKAL ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹5.64 |
| Mar2024 | ₹6.36 |
| Mar2023 | ₹13.02 |
| Mar2022 | ₹10.80 |
| Mar2021 | ₹6.85 |
How is Earnings Per Share (EPS) of HIKAL Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.64 | -11.32 | |
| Mar2024 | ₹6.36 | -51.15 | |
| Mar2023 | ₹13.02 | 20.56 | |
| Mar2022 | ₹10.80 | 57.66 | |
| Mar2021 | ₹6.85 | - | |
Compare Earnings Per Share (EPS) of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,392.0 Cr | -8.6% | -19.9% | -47.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -8.6% |
-19.9% |
-47.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses